Trademark: 75608796
Word
NOVALON PHARMACEUTICAL CORPORATION
Status
Dead
Status Code
710
Status Date
Saturday, March 14, 2009
Serial Number
75608796
Registration Number
2576979
Registration Date
Tuesday, June 11, 2002
Mark Type
1000
Filing Date
Friday, December 18, 1998
Published for Opposition
Tuesday, August 21, 2001
Cancellation Date
Saturday, March 14, 2009

Trademark Owner History
Novalon Pharmaceutical Corporation - Original Registrant

Classifications
1 Reagents for scientific or medical research use, namely phages used to isolate surrogate ligands of drug targets, and surrogate ligands used to isolate novel chemicals that can be developed into drugs
5 Reagents for clinical or medical laboratory use, namely phages used to isolate surrogate ligands of drug targets, and surrogate ligands used to isolate novel chemicals that can be developed into drugs
42 Drug discovery services, namely using phages to isolate surrogate ligands of drug targets, and using surrogate ligands to isolate novel chemicals that can be developed into drugs
"PHARMACEUTICAL CORPORATION"

Trademark Events
Mar 14, 2009
Cancelled Sec. 8 (6-Yr)
Sep 20, 2007
Case File In Ticrs
Jun 11, 2002
Registered-Principal Register
Oct 2, 2001
Extension Of Time To Oppose Received
Aug 21, 2001
Published For Opposition
Aug 1, 2001
Notice Of Publication
Feb 27, 2001
Approved For Pub - Principal Register
Oct 19, 2000
Correspondence Received In Law Office
Apr 28, 2000
Non-Final Action Mailed
Dec 17, 1999
Correspondence Received In Law Office
Jul 1, 1999
Non-Final Action Mailed
Jun 23, 1999
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24